Published in AIDS Weekly, February 27th, 2006
"Clarithromycin is a key agent in effective antimycobacterial therapy and prophylaxis for AIDS-related disseminated Mycobacterium avium complex (dMAC) infection. Immediate-release (IR) clarithromycin tablets are dosed at 500 mg bid for these indications," scientists writing in the journal HIV Clinical Trials report.
According to the authors, "A new extended-release (ER) tablet of clarithromycin has been developed and approved at a dosing interval of once every 24...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of AIDS Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.